Prevalence of BRCA1 and BRCA2 mutations in Ovarian Cancer patients in the Gulf region - PREDICT

Exclusion Criteria

• Patients who meet any of the following criteria are ineligible to participate in the study and hence will not be consented:
• 1. The diagnosis is not of a primary ovarian cancer; thus, patients will be excluded if a previous cancer has metastasized to the ovary, or if there is a secondary malignancy that is
• associated with the ovarian cancer.
• 2. Is not able or willing to provide written informed consent.
• 3. Have a diagnosis of other severe acute or chronic medical or psychiatric conditions that may increase the risk associated with study participation or may interfere with the interpretation of the study.
• 4. Be a patient who, in the judgment of the Investigator, would be inappropriate for enrollment in this study.
• A rationale will be documented for all patients who are screened and ultimately excluded from the study as a result of meeting any of the aforementioned exclusion criteria